A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
| Autor: | Herschorn, Sender a, Barkin, Jack a, Castro-Diaz, David b, Frankel, Jeffrey M. c, Espuna-Pons, Montserrat d, Gousse, Angelo E. e, Stölzel, Matthias f, Martin, Nancy g, Gunther, Adrie f, Van Kerrebroeck, Philip h, ∗ |
|---|---|
| Zdroj: | In Urology August 2013 82(2):313-320 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect